Login
Super Investors PRIMECAP Odyssey Growth Fund

PRIMECAP Odyssey Growth Fund

Primecap Odyssey Funds · net assets $6.06B · 180 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 97.8% · STIV: 2.2%

Financial position

Total assets
$6.07B
Total liabilities
$9.22M
Net assets
$6.06B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $66M $71.9M $97.1M
Reinvestment $0 $0 $0
Redemptions $95.3M $89.2M $108M
Net realized gain (non-derivative) $35.4M $32.9M $19.9M
Net unrealized appreciation (non-derivative) $842M $352M $-591M

The three months of the reporting period, as filed; month 3 ends July 31, 2026.

Filing details

Registrant
Primecap Odyssey Funds
Registrant CIK
1293967
Registrant LEI
5493004GQ7ACYH108358
Series
PRIMECAP Odyssey Growth Fund
Series ID
S000005540
Series LEI
254900D4M5B1SCROVT11
SEC file number
811-21597
Address
177 East Colorado Boulevard, 11th Floor, Pasadena, US-CA, 91105, US
Phone
626-304-9222
Form
NPORT-P
Filed
September 29, 2026
Report period ends
October 31, 2026
Report month ends
July 31, 2026
Accession number
000119312526406814
Holding Value % of net assets
Micron Technology Inc EC $615M 10.13%
Xometry Inc EC $298M 4.91%
Eli Lilly & Co EC $278M 4.58%
Intel Corp EC $264M 4.36%
Flex Ltd EC $200M 3.29%
Beone Medicines Ltd EC $185M 3.05%
Alphabet Inc EC $167M 2.76%
Biogen Inc EC $124M 2.05%
Charles Schwab Corp/the EC $115M 1.90%
Kla Corp EC $109M 1.80%
Microsoft Corp EC $104M 1.72%
Nvidia Corp EC $104M 1.71%
Rhythm Pharmaceuticals Inc EC $100M 1.65%
United Airlines Holdings Inc EC $98.7M 1.63%
Siemens Ag EC $93M 1.53%
Alibaba Group Holding Ltd EC $85.9M 1.42%
Astrazeneca PLC EC $81M 1.34%
Alphabet Inc EC $78.5M 1.29%
Southwest Airlines Co EC $76.6M 1.26%
Jabil Inc EC $73.6M 1.21%
Raymond James Financial Inc EC $70.9M 1.17%
Delta Air Lines Inc EC $70.4M 1.16%
Elanco Animal Health Inc EC $69.2M 1.14%
Marketaxess Holdings Inc EC $64.1M 1.06%
Amgen Inc EC $63.9M 1.05%
Amazon.com Inc EC $63.8M 1.05%
Jacobs Solutions Inc EC $63.1M 1.04%
Xencor Inc EC $62.6M 1.03%
Glaukos Corp EC $62.3M 1.03%
Northern Trust Corp EC $61.1M 1.01%
Baidu Inc EC $60.2M 0.99%
Biomarin Pharmaceutical Inc EC $58.4M 0.96%
Boston Scientific Corp EC $57.4M 0.95%
Nextpower Inc EC $54.9M 0.91%
Aecom EC $54.6M 0.90%
American Airlines Group Inc EC $53M 0.87%
First American Us Treasury Mon STIV $52.9M 0.87%
Visa Inc EC $51.3M 0.85%
Tesla Inc EC $49.8M 0.82%
Bristol-myers Squibb Co EC $47.9M 0.79%
Curtiss-wright Corp EC $47M 0.78%
Performance Food Group Co EC $45.7M 0.75%
Analog Devices Inc EC $44.8M 0.74%
Idex Corp EC $44M 0.73%
Goldman Sachs Financial Square STIV $39.6M 0.65%
Msilf Treasury Securities Port STIV $39.6M 0.65%
Hewlett Packard Enterprise Co EC $37.5M 0.62%
Livanova PLC EC $32.7M 0.54%
Netapp Inc EC $32.2M 0.53%
Biontech Se EC $32.1M 0.53%
Sony Group Corp EC $31.8M 0.52%
Adobe Inc EC $31.5M 0.52%
Conocophillips EC $31.3M 0.52%
Texas Instruments Inc EC $30.7M 0.51%
Gsk PLC EC $30.1M 0.50%
Dollar Tree Inc EC $28M 0.46%
Mongodb Inc EC $27.2M 0.45%
Citigroup Inc EC $26.8M 0.44%
Applied Materials Inc EC $25.1M 0.41%
Marvell Technology Inc EC $24.2M 0.40%

Showing top 60 of 180 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support